Charles River Laboratories International CRL
NYSE CRL
$350.80 +12.26 (+3.62%)
As of: Nov 3, 2026 · 3:59 PM EST

Charles River Laboratories International (CRL) Restructuring Costs (2017)

Updated

Charles River Laboratories International (CRL) reported Restructuring Costs of $18.1 million for Q4 2017.

Analysis

Charles River Laboratories International (CRL) Restructuring Costs (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 42.58 Bn 33.96 Bn 1.50 Bn
2 Medpace Holdings 18.13 Bn 15.77 Bn 223.89 Mn
3 Charles River Laboratories International 16.15 Bn 15.39 Bn 363.37 Mn
4 Icon 15.71 Bn 12.48 Bn 491.83 Mn
5 Fortrea Holdings 1.93 Bn 1.22 Bn 139.50 Mn
6 Ginkgo Bioworks Holdings 627.55 Mn -134.53 Mn 18.44 Mn
7 Evotec SE 540.45 Mn -1.07 Bn -
8 Champions Oncology 68.48 Mn 44.13 Mn 7.70 Mn
9 MindWalk Holdings 51.38 Mn 15.04 Mn 1.61 Mn
10 Natural Alternatives International 6.45 Mn -21.63 Mn 1.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 30, 2017 18.10 Mn
API Access

Charles River Laboratories International Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=CRL&period=max&api_key=YOUR_API_KEY